Scientific papers

Please use the menu on the right to browse publications by year, cancer type or author, or enter a search term in the box below.

Displaying 1 - 10 of 13 papers
Click here to reset all search parameters [1]

Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches [2]

Gomez-Rubio P, Piñero J, Molina-Montes E, Gutiérrez-Sacristán A, Marquez M, Rava M, Michalski CW, Farré A, Molero X, Löhr M, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberá VM, Crnogorac-Jurcevic T, Muñoz-Bellvís L, Domínguez-Muñoz E, et al.

Int J Cancer. 2018 Sep 19. [Epub ahead of print].
Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening [3]

O'Connor M, O'Leary E, Waller J, Gallagher P, Martin CM, O'Leary JJ, Sharp L.

Prev Med. 2018 Sep 6. [Epub ahead of print].
Screening status, tumour subtype, and breast cancer survival: a national population-based analysis [4]

O’Brien KM, Mooney T, Fitzpatrick P, Sharp L..

Breast Cancer Res Treat. 2018 Jul 13. [Epub ahead of print].
Health-related quality of life in a predictive model for mortality in older breast cancer survivors [5]

DuMontier C, Clough-Gorr KM, Silliman RA, Stuck AE, Moser A.

J Am Geriatr Soc. 2018;66(6):1115-1122.
Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group [6]

Derks MGM, Bastiaannet E, Kiderlen M, Hilling DE, Boelens PG, Walsh PM, van Eycken E, Siesling S, Broggio J, Wyld L, Trojanowski M, Kolacinska A, Chalubinska-Fendler J, Gonçalves AF, Nowikiewicz T, Zegarski W, Audisio RA, Liefers GJ, Portielje JEA, et al..

Br J Cancer. 2018;119(1):121-129.
Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania [7]

Breugom AJ, Bastiaannet E, Boelens PG, Van Eycken E, Iversen LH, Martling A, Johansson R, Evans T, Lawton S, O’Brien KM, Ortiz H.

Eur J Surg Oncol. 2018 May 26. [Epub ahead of print].
Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis? [8]

Minicozzi P, Walsh PM, Sánchez MJ, Trama A, Innos K, Marcos-Gragera R, Dimitrova N, Botta L, Johannesen TB, Rossi S, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2018;93:127-137.
Expecting the worst? The relationship between retrospective and prospective appraisals of illness on quality of life in prostate cancer survivors [9]

Maguire R, Hanly P, Drummond FJ, Gavin A, Sharp L.

Psychooncology. 2018;27(4):1237-1243.
Feller A, Schmidlin K, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Konzelmann I, Maspoli M, Wanner M, Zwahlen M, Clough-Gorr KM; SNC and the NICER Working Group [10]

Feller A, Schmidlin K, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Konzelmann I, Maspoli M, Wanner M, Zwahlen M, Clough-Gorr KM; SNC and the NICER Working Group.

Cancer Med. 2018;7(4):1498-1510.
Trends in incidence of thick, thin and in situ melanoma in Europe [11]

Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, et al.

Eur J Cancer. 2018;92:108-118.

Pages

[13]

[14]